Clincosm LogoSign in Get a demo

The Living Experience of Hong Kong Chinese Adolescents With CHD.

Sponsor
The University of Hong Kong (Other)
Overall Status
Completed
CT.gov ID
NCT03677232
Collaborator
(none)
30
Enrollment
1
Location
12.6
Actual Duration (Months)
2.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study aims to explore the impacts of CHD and its limitations on adolescents and the living experience of adolescents living with CHD.

Hong Kong Chinese adolescents with CHD are having reduced psychological well-being and quality of life than their healthy counterparts. Qualitative study is therefore needed to explore how CHD may impact on the adolescents' psychological well-being and quality of life.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    A qualitative study was adopted. Purposive sampling of 30 adolescents with CHD were done. Thematic analysis was used for data analysis. The participants unfold negative impacts of CHD and its treatments, and the challenges they were facing with their relationship with others.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    30 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    The Living Experience of Hong Kong Chinese Adolescents With CHD.
    Actual Study Start Date :
    Aug 11, 2017
    Actual Primary Completion Date :
    Aug 31, 2018
    Actual Study Completion Date :
    Aug 31, 2018

    Arms and Interventions

    Arm Intervention/Treatment
    Hong Kong Chinese adolescents with CHD

    Hong Kong Chinese adolescents with CHD aged 12-18 who are able to read and write chinese

    Outcome Measures

    Primary Outcome Measures

    1. living experience of adolescents with CHD [1 day]

      Participants were asked to describe their living experiences with CHD and how has CHD affected their quality of life and psychological well-being during the semi-structure interview.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Hong Kong Chinese adolescents

    • aged 12 to 18

    • able to read and write Chinese

    • attending outpatient clinic of Department of Pediatric Cardiology

    Exclusion Criteria:

    • adolescents with non-structural heart disease

    • with developmental delay or comorbid medical conditions

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Hong Kong Hong Kong Hong Kong

    Sponsors and Collaborators

    • The University of Hong Kong

    Investigators

    • Principal Investigator: William Li, PhD, The University of Hong Kong

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr. LI William Ho Cheung, Associate Professor, The University of Hong Kong
    ClinicalTrials.gov Identifier:
    NCT03677232
    Other Study ID Numbers:
    • UW 17-290
    First Posted:
    Sep 19, 2018
    Last Update Posted:
    Sep 19, 2018
    Last Verified:
    Sep 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dr. LI William Ho Cheung, Associate Professor, The University of Hong Kong
    Congenital Heart Disease, Hong Kong, Adolescent
    Additional relevant MeSH terms:
    Heart Diseases
    Heart Defects, Congenital

    Study Results

    No Results Posted as of Sep 19, 2018